Clinical trial
The Safety and Effectiveness of Zidovudine in HIV-Infected Pregnant Women and…
NCT00000960 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00000960 |
|---|---|
| Title | The Safety and Effectiveness of Zidovudine in HIV-Infected Pregnant Women and Their Infants |
| Official title | A Phase III Randomized Placebo-Controlled Trial to Evaluate the Efficacy, Safety and Tolerance of Oral Zidovudine (AZT) in Pregnant HIV Infected Women and Their Infants |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Collaborators | Glaxo Wellcome Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | HIV Infections, Pregnancy |
| Intervention type | Drug |
| Interventions | Zidovudine |
| Enrollment | 1,496 |
| Completion | Jun 1, 1994 |
| First posted | Aug 31, 2001 |
| Last update posted | Oct 29, 2021 |
| Countries | Puerto Rico, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: